[ACRX] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 9.07%
YoY- 19.28%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 265 613 377 818 343 740 1,487 -68.36%
PBT -13,674 -12,558 -12,458 -10,539 -11,592 -10,588 -13,013 3.36%
Tax 627 355 -2,601 2 136 -703 -3,233 -
NP -13,674 -12,558 -12,458 -10,541 -11,592 -9,885 -13,013 3.36%
Tax Rate - - - - - - - -
Total Cost 13,939 13,171 12,835 11,359 11,935 10,625 14,500 -2.59%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -5,160.00 -2,048.61 -3,304.51 -1,288.63 -3,379.59 -1,335.81 -875.12 226.73%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -3.47 -3.56 -4.15 -4.07 -4.55 -3.88 -5.61 -27.42%
EPS Diluted -3.47 -3.56 -4.15 -4.07 -4.55 -3.88 -5.61 -27.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.